Last update 21 Dec 2024
[18F]MNI-444
Last update 21 Dec 2024
Overview
Basic Info
Drug Type Small molecule drug, Diagnostic radiopharmaceuticals |
Synonyms- |
Target |
Mechanism A2aR antagonists(Adenosine A2a receptor antagonists), PET imaging(Positron-emission tomography enhancers) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Login to view timeline
Structure
Molecular FormulaC24H26FN9O2 |
InChIKeyQKAGUODENRFONW-FNNGWQQSSA-N |
CAS Registry1939792-98-9 |
Related
1
Clinical Trials associated with [18F]MNI-444A Phase 1 Proof of Principle Study to Evaluate the Occupancy of A2A Receptors Using PET Radiotracer [18F]MNI-444 & Repeated Dosing of Oral Caffeine in Participants Without Parkinson's Disease Who Carry Pathogenic Mutation in the LRRK2 Gene
100 Clinical Results associated with [18F]MNI-444
Login to view more data
100 Translational Medicine associated with [18F]MNI-444
Login to view more data
100 Patents (Medical) associated with [18F]MNI-444
Login to view more data
100 Deals associated with [18F]MNI-444
Login to view more data
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Diagnostic agents | Phase 1 | - | - | |
| Diagnostic agents | Phase 1 | - | - |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free